Versant Venture Capital Vi, L.p.

Affiliations

  • at Monte Rosa Therapeutics Inc. (GLUE), 2024-10-30
  • at Black Diamond Therapeutics Inc. (BDTX), 2024-08-30
  • at Tempest Therapeutics Inc. (TPST), 2024-08-13
  • Large Shareholder at Contineum Therapeutics Inc. (CTNM), 2024-04-11
  • at Lenz Therapeutics Inc. (LENZ), 2024-03-25
  • Large Shareholder at Oyster Point Pharma Inc. (OYST), 2023-01-04
  • Large Shareholder at Century Therapeutics Inc. (IPSC), 2022-08-11
  • Large Shareholder at Repare Therapeutics Inc. (RPTX), 2022-06-07
  • Large Shareholder at Aligos Therapeutics Inc. (ALGS), 2020-10-20
  • Large Shareholder at Pandion Therapeutics Inc. (PAND), 2020-07-21
  • Large Shareholder at Akero Therapeutics Inc. (AKRO), 2020-07-11
  • Large Shareholder at Passage Bio Inc. (PASG), 2020-03-04
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
GLUE $19.00 157,895 Large Shareholder 2,097,938 2021-06-28 Filing
IPSC $20.00 100,000 Large Shareholder 714,095 2021-06-22 Filing
ALGS $15.00 200,000 Large Shareholder 862,444 2020-10-20 Filing
PASG $18.00 225,000 Large Shareholder 933,352 2020-03-03 Filing
BDTX $19.00 396,081 Large Shareholder 1,206,603 2020-02-03 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
GLUE $9.41 15,600 1,573,453 2024-10-29 Filing
GLUE $9.08 52,305 1,589,053 2024-10-29 Filing
GLUE $9.66 89,990 2,007,948 2024-10-28 Filing
GLUE $6.53 1,132,566 5,099,336 2024-09-20 Filing
GLUE $6.16 9,269 6,231,902 2024-09-13 Filing